FDA+ channel feed – Endpoints News

FDA+ channel feed

FDA approves GSK's Jemperli for frontline use in certain advanced endometrial cancers

Last year

Republicans share draft bill to address drug shortages

Last year

As pressure mounts to take action on drug shortages, lawmakers seek to boost production in the US

Last year

Biohaven’s troriluzole rejected before FDA review

Last year

House, Senate committees mark up PBM bills as momentum for reform mounts

Last year

Octapharma wins FDA approval for drug to urgently reverse effects of blood thinners

Last year

Boehringer Ingelheim, Eli Lilly's Jardiance nabs approval in Europe for chronic kidney disease

Last year

Tarsus scores first FDA approval for treatment of red, itchy eyes caused by mites

Last year

Larimar to kick off higher dose of lead rare disease drug, initiate OLE trial

Last year

FDA approves Verrica's skin infection treatment, enters into non-binding term sheet for $125M loan

Last year

CHMP recommends against Mirati's KRAS rival, in favor of Pfizer's RSV vaccine, other drugs

Last year

Emergent’s newest anthrax vaccine is now FDA-approved

Last year

FDA approves Daiichi Sankyo's new first-line AML drug quizartinib with boxed warning for heart disorders

Last year

After seven patient deaths, ADC gets partial hold and decides to stop Zynlonta trial

Last year

Horizon adds 'severe hearing impairment' warning to blockbuster's label

Last year

FTC cautions against relying on its past PBM advocacy as industry pushes back

Last year

Despite Dem opposition, House committee advances pandemic preparedness bill sans drug shortage provisions

Last year

House Republicans question FDA's progress on pharma inspections in India and China

Last year

CMS proposes new coverage policy for Alzheimer's-related PET scans

Last year

Ingredient manufacturer Centaur gets FDA warning over records, substandard cleaning

Last year

Manufacturers, industry groups comment on FDA’s control over nitrosamines in drug products

Last year

After yearlong delay, FDA completes inspection for Novartis, BeiGene's anti-PD-1 drug from China

Last year

Bipartisan group of senators seeks to eliminate interchangeability designation for biosimilars

Last year

FDA approves another RSV option, this time it's Sanofi and AstraZeneca’s antibody drug for infants

Last year

First page Previous page 50 51 525354 55 56 Next page Last page